This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Denmark
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This study is looking at whether 1 can help people with Schizophrenia, schizophreniform disorder, schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
In Netherlands
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOther
Countries
Netherlands
Sponsor
The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
